Antonio Ceriello Selected Research

Diabetes Complications

1/2021	Variability of risk factors and diabetes complications.
1/2020	Glucose Variability and Diabetic Complications: Is It Time to Treat?
1/2017	The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.
5/2016	The Possible Role of Flavonoids in the Prevention of Diabetic Complications.
11/2013	Glucose variability: An emerging target for the treatment of diabetes mellitus.
11/2012	The emerging challenge in diabetes: the "metabolic memory".
2/2011	Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.
1/2011	Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole.
9/2010	[Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors].
12/2009	Hypothesis: the "metabolic memory", the new challenge of diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Ceriello Research Topics

Disease

97	Type 2 Diabetes Mellitus (MODY) 05/2022 - 02/2002
51	Hyperglycemia 03/2022 - 04/2002
22	Diabetes Complications 01/2021 - 08/2002
22	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2004
17	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2005
16	Inflammation (Inflammations) 06/2022 - 05/2005
16	Hypoglycemia (Reactive Hypoglycemia) 02/2020 - 01/2007
10	Heart Failure 01/2022 - 01/2007
9	COVID-19 06/2022 - 01/2020
9	Insulin Resistance 05/2021 - 05/2004
9	Albuminuria 11/2020 - 09/2015
9	Hypertension (High Blood Pressure) 11/2020 - 02/2008
9	Glucose Intolerance 07/2020 - 10/2002
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 03/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 05/2006
6	Body Weight (Weight, Body) 01/2021 - 10/2008
5	Overweight 01/2022 - 09/2008
5	Atherosclerosis 01/2020 - 01/2005
5	Myocardial Infarction 07/2011 - 12/2004
4	Weight Loss (Weight Reduction) 01/2022 - 01/2008
4	Thrombosis (Thrombus) 01/2021 - 02/2013
4	Kidney Diseases (Kidney Disease) 01/2021 - 11/2015
4	Weight Gain 03/2020 - 02/2011
4	Chronic Renal Insufficiency 12/2019 - 07/2016
4	Diabetes Mellitus 12/2017 - 11/2007
4	Obesity 02/2015 - 01/2008
3	Abdominal Obesity 01/2020 - 04/2008
3	Hyperlipidemias (Hyperlipidemia) 08/2019 - 10/2004
3	Neoplasms (Cancer) 12/2018 - 12/2010
3	Necrosis 03/2018 - 05/2006
3	Chronic Disease (Chronic Diseases) 05/2008 - 08/2006
2	Peripheral Arterial Disease 02/2022 - 03/2007
2	Acute Coronary Syndrome 01/2021 - 07/2011
2	Prediabetic State (Prediabetes) 07/2020 - 02/2015
2	Periodontitis 03/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

68	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2002
36	Insulin (Novolin)FDA Link 03/2022 - 08/2002
21	Blood Glucose (Blood Sugar)IBA 01/2022 - 05/2004
16	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 02/2005
16	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 03/2011
13	AntioxidantsIBA 06/2017 - 10/2002
12	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2017
12	LipidsIBA 01/2021 - 05/2006
11	Triglycerides (Triacylglycerol)IBA 08/2019 - 01/2007
10	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 05/2006
9	LDL CholesterolIBA 02/2022 - 01/2007
9	oxidized low density lipoproteinIBA 01/2020 - 01/2007
9	HDL CholesterolIBA 08/2019 - 01/2007
8	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2018
8	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 01/2008
8	Free RadicalsIBA 02/2008 - 05/2003
8	Superoxides (Superoxide)IBA 02/2008 - 05/2003
7	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2006
7	CarbohydratesIBA 05/2021 - 08/2006
7	3-nitrotyrosineIBA 11/2014 - 04/2002
6	Uric Acid (Urate)IBA 01/2021 - 11/2015
6	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
6	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 10/2016
6	Liraglutide FDA Link 02/2020 - 02/2012
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 05/2005
6	Interleukin-6 (Interleukin 6)IBA 11/2014 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 03/2003
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2019 - 01/2006
5	Vitamin E FDA LinkGeneric 03/2007 - 05/2003
5	Peroxynitrous Acid (Peroxynitrite)IBA 05/2006 - 08/2002
4	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2021 - 06/2017
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 09/2010
4	Pharmaceutical PreparationsIBA 01/2020 - 05/2006
4	InterleukinsIBA 03/2018 - 05/2006
4	Hemoglobins (Hemoglobin)IBA 09/2015 - 01/2007
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2013 - 07/2007
4	Oxygen (Dioxygen)IBA 01/2007 - 05/2003
3	mesoglycanIBA 11/2021 - 10/2013
3	AlbuminsIBA 01/2021 - 01/2016
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
3	OsteoprotegerinIBA 12/2020 - 01/2018
3	SodiumIBA 01/2020 - 07/2014
3	Pioglitazone (Actos)FDA Link 01/2020 - 02/2005
3	C-Reactive ProteinIBA 01/2020 - 12/2004
3	NF-kappa B (NF-kB)IBA 03/2018 - 01/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2016 - 10/2002
3	Adenosine Triphosphate (ATP)IBA 05/2007 - 10/2004
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 01/2007
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 09/2010
2	C-PeptideIBA 12/2020 - 01/2020
2	empagliflozinIBA 10/2020 - 01/2016
2	AngiotensinsIBA 01/2020 - 10/2004
2	Transcription Factors (Transcription Factor)IBA 12/2019 - 01/2007
2	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 09/2016
2	CholesterolIBA 01/2019 - 03/2014
2	LigandsIBA 03/2018 - 01/2018

Therapy/Procedure

32	Therapeutics 01/2022 - 05/2003
24	Glycemic Control 03/2022 - 12/2004
5	Injections 01/2022 - 11/2007
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
3	Mediterranean Diet 11/2014 - 05/2008
2	Surgical Amputation (Amputations) 01/2020 - 05/2008
2	Contraindications 01/2020 - 06/2013
2	Secondary Prevention 01/2020 - 08/2010